e-learning
resources
Berlin 2008
Tuesday, 07.10.2008
Epidemiological and clinical aspects of tuberculosis control
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Observation results of 484 patients that use TNF alfa inhibitor in respect of the risk of tuberculosis
T. Cagatay, M. Aydin, Z. Gulbaran, R. Yildiz, L. Pur, A. Gul, M. Inanc, S. Kamali, B. Artim, Y. Cagatay, Z. Kilicarslan (Istanbul, Turkey)
Source:
Annual Congress 2008 - Epidemiological and clinical aspects of tuberculosis control
Session:
Epidemiological and clinical aspects of tuberculosis control
Session type:
E-Communication Session
Number:
3051
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Cagatay, M. Aydin, Z. Gulbaran, R. Yildiz, L. Pur, A. Gul, M. Inanc, S. Kamali, B. Artim, Y. Cagatay, Z. Kilicarslan (Istanbul, Turkey). Observation results of 484 patients that use TNF alfa inhibitor in respect of the risk of tuberculosis. Eur Respir J 2008; 32: Suppl. 52, 3051
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
The incidence of tuberculosis in patients taking anti TNF alpha therapy
Source: Annual Congress 2011 - Tuberculosis in immunocompromised hosts
Year: 2011
Follow up results of patients receiving anti tumor necrosis antagonists and evaluation of risk of tuberculosis
Source: Annual Congress 2009 - Clinical immunology of tuberculosis
Year: 2009
Follow up results for tuberculosis in patients who receive TNF antagonist treatment
Source: Eur Respir J 2007; 30: Suppl. 51, 659s
Year: 2007
Characteristics of new tuberculosis cases diagnosed during treatment with TNF-alpha antagonists
Source: Annual Congress 2009 - Clinical immunology of tuberculosis
Year: 2009
Effectiveness of official recommendations on tuberculosis screening in patients on TNF antagonists
Source: Annual Congress 2010 - Tuberculosis: metabolic insights
Year: 2010
Diagnostic performance of the interferon gamma release assay in elderly patients and clinical factors to support the diagnosis of active tuberculosis
Source: Annual Congress 2012 - Tuberculosis and immunologic assays
Year: 2012
Our approach about latent tuberculosis infection in patients who are given anti-TNF alpha therapy
Source: Annual Congress 2009 - Clinical immunology of tuberculosis
Year: 2009
Screening and monitoring of tuberculosis in patients on tumor necrosis factor antagonist therapy
Source: Annual Congress 2011 - Clinical challenges in tuberculosis
Year: 2011
Risk of tuberculosis in pediatric patients treated with biological agents
Source: Virtual Congress 2020 – Aspects of acute and chronic airway infections in children
Year: 2020
The use of tumor necrosis factor alpha inhibitor pentoxifylline in the treatment of patients with I and II stages of pulmonary sarcoidosis
Source: Eur Respir J 2006; 28: Suppl. 50, 542s
Year: 2006
An evaluation of the use of a negative interferon gamma release assay for tuberculosis screening before TNF antagonist therapy
Source: Eur Respir J 2014; 44: 1369-1372
Year: 2014
Comparison of LTBI screening strategies before TNF inhibitor treatment in inflammatory arthritis
Source: International Congress 2018 – Tuberculosis transmission and screening strategies
Year: 2018
Treatment and outcome of CRF patients with tuberculosis
Source: Annual Congress 2010 - Adverse events of antituberculosis treatment and comorbidities
Year: 2010
Risk Factors for tuberculosis in patients on anti-TNF treatment
Source: International Congress 2019 – Tuberculosis and comorbidities
Year: 2019
Screening and monitoring of tuberculosis in patients on biologics treatment
Source: Annual Congress 2012 - Tuberculosis: clinical findings I
Year: 2012
Long-term results of treatment with bedaquiline in patients with drug-resistant tuberculosis
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020
Factors affecting the efficacy of treatment of MDR/XDR TB patients receiving bedaquiline
Source: International Congress 2019 – Tuberculosis: a public health approach
Year: 2019
Comparison of treatment outcomes in community-acquired pneumonia patients treated with beta lactam-macrolide combination versus fluoroquinolone monotherapy
Source: Annual Congress 2012 - Management of severe respiratory infections
Year: 2012
Antiviral biomarkers are upregulated in sputum cells following administration of inhaled interferon beta to COPD patients
Source: International Congress 2019 – COPD clinical trials: new molecules and novel insights
Year: 2019
Relationship of interleukin 10 1082 G/A gene polymorphism with the duration of nephrotoxic onset due to anti tuberculosis drugs in multi drug resistant tuberculosis patients
Source: International Congress 2019 – Tuberculosis: diagnosis
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept